RxDoctor Payments Data

Lance Real, DO

Family Medicine · Lithia, FLNPI 1497733091

Payments from drug & device makers

$1,554in general payments, 2019–2025

Across 74 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$472
  • Exact Sciences$163
  • AbbVie$152
  • AstraZeneca$151
  • Pfizer$138
  • Lilly USA, LLC$130
  • plus $349 from 10 others

What the payments were for

  • Food & beverage$1,554100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,554 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$12,650
Medicare patients
162
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide55$55,653
JardianceEmpagliflozin81$54,061
XareltoRivaroxaban73$46,076
OzempicSemaglutide47$45,563
EliquisApixaban40$27,397
FarxigaDapagliflozin Propanediol33$18,857
JanuviaSitagliptin Phosphate34$15,048
Stiolto RespimatTiotropium Br/Olodaterol Hcl24$14,372
MyrbetriqMirabegron23$12,781
TradjentaLinagliptin19$12,065
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,506
LinzessLinaclotide12$6,328
Carbamazepine ErCarbamazepine24$5,924
Incruse ElliptaUmeclidinium Bromide13$5,720
ShingrixVaricella-Zoster Ge/As01b/Pf26$5,615

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat, Tradjenta$23$80,497124 claims
Lilly USA, LLCTrulicity$130$55,65355 claims
Johnson & JohnsonXarelto$15$46,07673 claims
Novo NordiskOzempic$472$45,56347 claims
PfizerEliquis$138$27,39740 claims
AstraZenecaFarxiga, Symbicort$151$22,43349 claims
MerckJanuvia$41$15,04834 claims
AbbVieLinzess$152$6,32812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Lithia

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →